RxNorm Concept ID 1863347

Vincasar 1 MG in 1 ML Injection

Semantic Concepts

RxNorm semantic concepts for the RxCUI 1863347 unique identifier include: Vincasar 1 MG in 1 ML Injection (8709499), 1 ML vincristine sulfate 1 MG/ML Injection [Vincasar] (12371762), Vincasar 1 MG per 1 ML Injection (8709500), 1 ML VCR Sulfate 1 MG/ML Injection [Vincasar] (8711680) and 1 ML vinCRIStine sulfate 1 MG/ML Injection [Vincasar] (12381053).

RxNorm Atom ID: 8709499 - Prescribable Name

Vincasar 1 MG in 1 ML Injection

Field NameField ValueField Description
RXCUI1863347RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI8709499Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionVincasar 1 MG in 1 ML InjectionDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE1863347"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12371762 - Semantic Branded Drug

1 ML vincristine sulfate 1 MG/ML Injection [Vincasar]

Field NameField ValueField Description
RXCUI1863347RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12371762Unique identifier for the atom (RxNorm Atom ID)
Concept Description1 ML vincristine sulfate 1 MG/ML Injection [Vincasar]Description of concept identifier
Term Type (TTY)SBDTerm type in source with name and description
Term Type NameSemantic Branded DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose Form + Brand NameDescription of term type in source
CODE1863347"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12371762 Attributes

PropertyValueExplanation
RXN AI{894892} 11203RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{894892} 11202RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH1 MG/MLAvailable drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{894892} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans
RXN QUANTITY1 MLNormal Form quantity factor

RxNorm Atom ID: 8709500 - Synonym

Vincasar 1 MG per 1 ML Injection

Field NameField ValueField Description
RXCUI1863347RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI8709500Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionVincasar 1 MG per 1 ML InjectionDescription of concept identifier
Term Type (TTY)SYTerm type in source with name and description
Term Type NameSynonymName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity.Description of term type in source
CODE1863347"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 8711680 - Synonym

1 ML VCR Sulfate 1 MG/ML Injection [Vincasar]

Field NameField ValueField Description
RXCUI1863347RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI8711680Unique identifier for the atom (RxNorm Atom ID)
Concept Description1 ML VCR Sulfate 1 MG/ML Injection [Vincasar]Description of concept identifier
Term Type (TTY)SYTerm type in source with name and description
Term Type NameSynonymName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity.Description of term type in source
CODE1863347"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12381053 - Tall Man Lettering Synonym

1 ML vinCRIStine sulfate 1 MG/ML Injection [Vincasar]

Field NameField ValueField Description
RXCUI1863347RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12381053Unique identifier for the atom (RxNorm Atom ID)
Concept Description1 ML vinCRIStine sulfate 1 MG/ML Injection [Vincasar]Description of concept identifier
Term Type (TTY)TMSYTerm type in source with name and description
Term Type NameTall Man Lettering SynonymName of term type in source
Term Type DescriptionTall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.Description of term type in source
CODE1863347"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Vincristine Injection

Vincristine is used in combination with other chemotherapy drugs to treat certain types of leukemia (cancer of the white blood cells), including acute myeloid leukemia (AML, ANLL) and acute lymphoblastic leukemia (ALL), Hodgkin's lymphoma (Hodgkin's disease), and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection). Vincristine is also used in combination with other chemotherapy drugs to treat Wilms tumor (a type of kidney cancer that occurs in children), neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children), and rhabdomyosarcoma (cancer that forms in muscles in children). Vincristine is in a class of medications called vinca alkaloids. It works by slowing or stopping the growth of cancer cells in your body.
[Read More]
Cancer Chemotherapy

Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.

You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.

Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).

NIH: National Cancer Institute


[Read More]

* Please review the disclaimer below.